https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, October 10, 2022


Published: Monday, October 10, 2022

OUHSC Research News – Monday, October 10, 2022

 

Notices and Reminders

ORA Reminder for Principal Investigators and Their Support Teams

Please ensure that all key personnel on your project complete their Compliance Forms in SoonerTrack as soon as you submit your Request Form in the system. Your Request Form is not considered received by ORA if Compliance Forms are not approved by all key personnel. This can cause a delay in submitting your proposal to the funding agency and potentially a risk of missing the submission deadline.

Principal Investigators (and their support teams) retain primary responsibility for ensuring that all these approvals are complete before the deadline. So, please check the status of your Key personnel’s Compliance Forms after submitting your proposal in SoonerTrack to ensure a smooth submission process.

 

IMPORTANT SOONERTRACK UPDATE: Off-Campus Access to SoonerTrack II

The Office of Research Administration (ORA) is excited to announce that SoonerTrack II is now accessible off-campus through Self-Service at: selfservefs.ou.edu. As a result, you will not need to use the GlobalProtect VPN (Virtual Private Network) or MyDesk VDI service (Virtual Desktop Infrastructure) when off-campus to access the SoonerTrack II system. However, DUO dual authentication is still required. Please note that mobile devices such as cell phones are not fully compatible at this time. If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

 

OUHSC Research News is intended to notify faculty and staff of new funding opportunities, upcoming workshops and seminars, agency updates, and OUHSC policies and procedures that impact sponsored research. If your department or unit has an open funding opportunity or is offering a workshop event that you’d like to be included in the newsletter, please send it to the Office of Research Administration (ORA) at oradmin@ouhsc.edu. Items for the newsletter should be received by the ORA on later than 5:00 PM on Thursday to be included in the following week’s issue.   

 

Workshops and Seminars

OUHSC and OU-Norman combined Bioinformatics Mini-Symposium

Description: A mini-symposium is being planned on the OU-Norman to bring together Bioinformatics and Computational Biology researchers from both the OU-Norman and OUHSC campuses. The goal of this mini-symposium is to establish collaborations between OUHSC researchers performing Omics analyses with the Informatics Department at OU-Norman so that together we can build a highly skilled workforce for analyses of R and Python based Omics technologies, including single cell RNA sequencing and spatial transcriptomics. At the symposium, we will highlight current work being done in the single cell Omics field at OUHSC and provide an overview of how high-end computational approaches to Omics could further biomedical research projects on both campuses. Overall, we aim to foster collaboration in research and education, increase the understanding of state-of-the-art Omics tools and techniques, and explore avenues for increasing our bioinformatics and computationally skilled workforce to support Bioinformatics/Computer Biology analyses on the OUHSC and OU-Norman campuses.  If you are currently performing Omics research, plan to perform Omics research, or are interested in learning about Omics research, please contact either darrin-akins@ouhsc.edu or james-papin@ouhsc.edu for further information as we set a date for the symposium planned for this fall.

 

Virtual Information Session: Understanding the New NIH Data Management and Sharing (DMS) Policy

Date: October 26, 2022; 10:00–11:00 AM Central Time

Description: Effective January 25, 2023, researchers are required to submit in their NIH grant application a written plan for how scientific data will be preserved and shared. The Office of Research Administration (ORA) is hosting this virtual session to cover the key information about the NIH DMS policy behind the plan, introduce the components of a data management and sharing plan, and share resources available to the faculty. 

Registration: Please register here to attend.

Questions: Should you have any questions or need more information, please contact Sogol Rasouli at sogol-rasouli@ouhsc.edu. 

 

Neuroscience Symposium, OUHSC Department of Neurosurgery and the Neuroscience Program

The department of Neurosurgery and the Neuroscience program are hosting a symposium on Friday, October 21th, 2022. Please refer to the attached flyer for more information.

Event Date: Friday, October 21, 2022 7:30 am - 2:00 pm

Where: Samis Educational Center, Main Lecture Hall, OU Children's Hospital

 

The National Symposium on Sexual Behavior of Youth Call for Poster Abstracts

Description: Join your colleagues on Wednesday, February 22, 2023 from 5:00p - 7:00p for the multi-disciplinary NSSBY poster session that will highlight the latest research, programs, and activities in the field.  Light snacks will be available during the poster session, which will be concurrent with the Welcome Reception.  The poster session provides opportunities for extended discussion with symposium participants about your work.
Poster submissions must be received by November 30, 2022.  Announcements of acceptance will be made by December 15, 2022.  
Posters describing innovative programs and implementation strategies are encouraged and welcomed.  Posters can focus on a wide variety of topics related to the sexual behavior of youth, such as:

  • sexual development
  • sex education
  • healthy sexual behavior
  • impact of technology
  • problematic/harmful and/or illegal sexual behavior
  • assessment
  • treatment
  • long-term outcomes

More information can be found at: https://connect.ncsby.org/nssby2023/call-for-proposals/posters

Questions? OU-NCSBY@ouhsc.edu

 

NIH Webinar: Research Misconduct & Detrimental Research Practices Webinar

Date: October 14, 2022, 2:10 PM – 3:15 PM EST

Description: What is research misconduct and what are some detrimental research practices? Research Integrity Officers from the Office of Research Integrity (ORI), HHS and NIH will help answer this question and more, as they discuss Public Health Service (PHS) regulations on handling research misconduct allegations, responsibilities of an institution receiving PHS funds, and red flags that may help to avoid misconduct in research. Experts will explore interpersonal, institutional, and professional responsibilities in the overall ethical conduct of research during presentations, case studies, and discussions with the audience. Registration is free and includes access for the NIH Grants Conference 2022-2023 season.

Registration link: https://grants.nih.gov/learning-center/conference/precon-events/research-misconduct

 

Team building and research development for projects in health, well-being, and the built environment (Workshop 2 of 2)

Date/Time: Friday, October 21, 9:00 a.m. -12:00 pm Central

One sentence summary of the event:  This second of two interactive workshops has OU Norman and OU HSC researchers pitch their collaborative research ideas and participate in activities to further trans-disciplinary aspects and align with funding opportunities in the area of health, well-being, and the built environment.

Description: Join CFE, along with Susan Sisson (Allied Health) and Angela Person (Gibbs College), in the second of two workshops to further develop ideas for collaborative proposals related to health, well-being, and the built environment. Participation in both workshops is not required, but suggested.

During this session, OU researchers will share the basic idea of their team research, receive feedback from grant writing experts, develop a plan to reach out to program managers, and further prepare for the internal seed grant funding opportunity aimed at securing external funding in the future. Don't have something to pitch or didn't attend the first workshop? Faculty from OU Norman and OU HSC are encouraged to attend to learn more.

Event Venue/Location: In-person on the OU Norman campus. Location information follows registration

Registration link: https://ousurvey.qualtrics.com/jfe/form/SV_bjgGl4HK21Fr14i

RFP: https://bit.ly/3R8Prc4

Point of contact: Clara Smith, clara.smith@ou.edu [same person as for workshop 1]

 

OUHSC Funding Opportunities

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

  • Cycle III PHF Bridge Grant Program Deadline: November 4, 2022

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an

extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found here.  If you have any questions, please email  VPR@ouhsc.edu.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • Cumulus Oncology seeks to engage with academia for small molecule and biologics platforms that are GPCR targeted, specifically demonstrating therapeutic activity in oncology.  All cancers are within scope with solid tumors being of highest interest.  Early stage opportunities with hit identification or initial biologics development targeting the receptor are of interest.  Out of scope:  drug repurposing, gene therapy and cell-based therapeutics. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/08).
  • A top consumer goods company is seeking new solutions (improved manufacturing processes or new raw materials) to address the carbon footprint associated with personal care formulations (bar soap, liquid and foaming hand wash, and body wash).   Approaches of interest include soap noodles, alkyl sulphates and alkyl ether sulphates; raw material substitutes must be sustainable, non-GMO and non-animal derived.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/08).
  • Bicycle Therapeutics, a clinical stage biopharmaceutical company, is seeking research proposals to enhance their understanding of how their novel peptide “Bicycles” interact with P-selectin in Disease.  Submission entails completion of an application form, available at discover.in-part.com. (deadline 11/01).
  • RHI Magnesita is looking for innovative solutions for refractory products in which damage mechanism trigger the complete recovery of functionality, and additives which block or prevent wear mechanisms from growing.  Out of scope are approaches that use toxic materials, changing of a customer process, or ideas already present in industry practice.   Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/01).
  • Novelis, a world leader in aluminum rolling and recycling,  is looking to implement a robust system to measure and trend the forces created during the aluminum can body forming process.  The system should be able to wirelessly measure friction and load with high-speed data acquisition and must be capable of running in a production environment. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/01).

 

 

NIH Notices 

 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

Call for Pre-Proposals Early K99/R00 Funding Opportunity Announcements

NCI just reissued so-called “early K99/R00” - NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers Funding Opportunity Announcements (FOAs).

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-035.html

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-036.html

https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-037.html

This Early K99/R00 award in many respects, such as duration, financial support, etc. is similar to the parent K99/R00. However, there are several important differences:

  • Only postdoctoral (or postdoc-like) researchers with less than 2 years of postdoctoral research experience by the submission due date (February 28, 2023) are eligible to apply
  • Each candidate must be nominated by the institution and a nomination letter (2 pgs max) must be included in the application (refer to the FOAs for the requirements)
  • Each institution may submit up to 3 applications, but each application must be in a different field of science: one in data science, one in cancer control science and one in other sciences. Please refer to the FOAs for the field of science definition
  • Early K99/R00 applications are reviewed by a special emphasis panel, therefore, they are not competing with the regular/parent K99/R00.
    • Preliminary data are not required
    • Publication with the current/postdoctoral mentor are not required

Pre-proposal is due to Stevie Warner by November 18, 2022. The Education, Training, and Career Enhancement Core will organize a review committee and select an applicant from each field of science to nominate for submission. This selection and notifications will take place by December 2, 2022 to allow the selected candidates ample time to write their full application.

  • Specific Aims page
  • Biosketch
  • Letter of Support from Mentor

Application Due Date: Submissions must be received by February 28, 2023 at 5:00 PM local time of applicant organization.

Pre-application informational webinar: NCI is planning to hold a pre-application informational webinar on November 7, 2023, 2:00 PM ET

https://cbiit.webex.com/cbiit/j.php?MTID=maa609f6ee5a92e217cf9affd5fd3aa85

Monday, Nov 7, 2022 2:00 pm | 1 hour | (UTC-04:00) Eastern Time (US & Canada)

Meeting number: 2311 987 0275

Password: aQW7Nyd74g@

Join by video system

Dial 23119870275@cbiit.webex.com

You can also dial 173.243.2.68 and enter your meeting number.

Join by phone

1-650-479-3207 Call-in toll number (US/Canada)

Access code: 231 198 70275

 

Cystic Fibrosis Foundation Medical Resident Research Award

Description: This award is part of the Cystic Fibrosis Foundation’s Physician Scientist Training Program and is designed to introduce residents to cystic fibrosis research with the goal to develop and maintain interest in a career in CF research or as a CF care provider. Awards support up to $10,000 in salary or research related costs for one year and applications are accepted on a rolling basis at awards.cff.org. For questions, please contact Liz Yu (eyu@cff.org).

Applications Due: November 15, 2023

Link to Full Announcement: https://www.cff.org/researchers/medical-resident-research-award

 

Cystic Fibrosis Foundation Idea Development Award

Description: The Spring 2023 Idea Development Award (IDA) is intended to support work that leads to sufficient project development to enable an application for future research funding from the Cystic Fibrosis Foundation or the National Institutes of Health. For more information, visit the IDA webpage.  For questions, please contact Dara Riva (driva@cff.org).

Applications Due: February 2, 2023

Link to Full Announcement: https://www.cff.org/researchers/idea-development-award

 

Cystic Fibrosis Foundation /NIH K-Unfunded Award

Description: The CFF/NIH K-Unfunded Award offers a temporary mechanism for supporting highly meritorious K-award applicants until NIH funding can be obtained. To be considered for this program, applications clearly relevant to advancing the Foundation mission must have been submitted to NIH as a K01, K08, K22, K23, K24, K25 or K99/R00 application. The application must have been reviewed by an NIH study section and presented to an institute council within 12 months of applying for Foundation support. If awarded, a revised application must be submitted to the NIH within one year of receiving the Foundation award. The CF Foundation offers funding of up to $80,000 per year for up to two years.

Applications Due: November 3, 2022

Link to Full Announcement: https://www.cff.org/researchers/cf-foundationnih-k-unfunded-award

 

ASPIRE: A Supplement to Promote Inclusion for Research Excellence

Description: Despite progress in breast cancer research and patient care, not everyone is benefitting from the scientific advances and improvements in breast cancer care and outcomes.  This new Susan G. Komen grant is intended to enhance the diversity of the breast cancer research workforce by providing established breast cancer scientists with supplemental funding to support research trainees from communities historically minoritized and marginalized in research. A breast cancer research workforce that represents the breast cancer community is one way to work towards health equity and better outcomes for all. By supporting these promising trainees early in their research careers, Komen seeks to ensure that a diverse group of highly trained scientists who reflect the communities we serve will emerge as the next generation of leaders in breast cancer research and end breast cancer forever. 

Eligibility: Lead mentor must have a currently funded breast cancer research project that has undergone a rigorous peer review by either Susan G. Komen, the Department of Defense, the National Institutes of Health (NIH) or the National Science Foundation (NSF). Trainees supported by this supplement must be from one or more the following racial and ethnic groups that have been shown to be underrepresented in biomedical research, as per data from the 2021 US National Science Foundation report on Women, Minorities, and Persons with Disabilities in Science and Engineering:  Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islander. (https://diversity.nih.gov/about-us/population-underrepresented). Supported trainees may include predoctoral students (post qualifying exam), health professional students, and postdoctoral fellows.

Award amount: up to $80,000 per year to cover a trainee’s salary for one year or two years.

Full Application Due: November 1, 2022, by 1 p.m., Eastern Standard Time

Link to Full Announcement: https://bit.ly/3xmfvcn

 

Melanoma Research Alliance (MRA) - 2022-2023 Request for Proposals

Description: The Melanoma Research Alliance (MRA) is pleased to announce a Request for Proposals (RFP) for pre-clinical, translational, and early clinical research with the potential to produce unusually high impact, near-term advancements in melanoma prevention, detection, diagnosis, and treatment.

Proposals will be accepted for Established Investigator Awards, Academic-Industry Partnership Awards, Young Investigator Awards, and Pilot Awards. Special Opportunities Included in RFP:

  • Immunotherapy Young Investigator Awards supported by Bristol Myers Squibb (BMS)
  • Radiation Oncology Young Investigator Award co-funded with the American Society for Radiation Oncology (ASTRO)
  • Metastatic Uveal Melanoma Pilot Award co-funded with A Cure in Sight
  • Patient-Centric Clinical Trials Team Science Awards co-funded with the Rising Tide Foundation for Clinical Cancer Research (RTFCCR) 

Deadline for Young Investigator applicants to submit Applicant Eligibility Checklist: October 19, 2022

Deadline for all Individual Awards (EIA, YIA, and Pilot) proposals: November 2, 2022

Deadline for invited full applications for RTFCCR-MRA Team Science Awards: January 18, 2023

Link to Full Announcement: https://www.curemelanoma.org/research/request-for-proposals/mra-general-rfp/

 

 

 

Documents to download